Overview

MK0767 in Metabolic Syndrome-Dyslipidemia (0767-016)

Status:
Terminated
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial in patients with Metabolic Syndrome and Dyslipidemia to study the effects of MK0767 on triglycerides.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Fenofibrate